Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male
NCT01688193 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68
Last updated 2013-01-07
Summary
The purpose of this study is to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male
Conditions
Sponsors & Collaborators
-
Hanmi Pharmaceutical Company Limited
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Surveillance of Humira Injection in Korean Patients
NCT01083121 ·Status: COMPLETED
-
A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis
NCT06625242 ·Status: COMPLETED ·Phase: PHASE4
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
NCT06902519 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study
NCT00612885 ·Status: COMPLETED
-
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics
NCT01636817 ·Status: TERMINATED ·Phase: PHASE2
-
Proximod Pharmacokinetics in Healthy Subjects and Patients With Rheumatoid Arthritis
NCT06361199 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real World
NCT03264703 ·Status: COMPLETED
-
An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis
NCT01669902 ·Status: COMPLETED
-
A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523
NCT02105129 ·Status: COMPLETED ·Phase: PHASE1
-
Proximod Pharmacokinetics In Healthy Subjects
NCT06361186 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis
NCT04541810 ·Status: COMPLETED
-
Study of the Tolerability of Different SAR153191 Drug Products, That Differ With Respect to Manufacturing Processes and Formulation, at Different Concentrations and Doses in Healthy Male Subjects
NCT06159452 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT00409838 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients
NCT01559103 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis
NCT01990157 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment
NCT05165771 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Iguratimod in Patients With Active Rheumatoid Arthritis
NCT01554917 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis
NCT01317797 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.
NCT03605251 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy Participants
NCT06115967 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy
NCT01751776 ·Status: COMPLETED ·Phase: PHASE1
-
Leflunomide + Methotrexate in Rheumatoid Arthritis
NCT00563849 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
NCT02528188 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
NCT01089023 ·Status: COMPLETED ·Phase: PHASE4
-
Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00235859 ·Status: COMPLETED ·Phase: PHASE3